BIOS:
My work is focused on decoding the epigenomic pathophysiology in different gynecological cancers, especially ovarian and endometrial cancer for the identification of potential clinical biomarkers which might be used for the development of improved diagnostics. Further, we are also working to explore small molecules and RNA-based methods for early and precision cancer detection. Besides, we also wish to employ and establish genome-editing technologies for deciphering novel mechanisms of non-coding RNA dysregulation in oncogenesis, and also in the development of novel AI-based precision diagnostics and targeted therapeutics.